Trump Drug Pricing Deal with Dr. Mehmet Oz: Understanding the New Rules for Wegovy, Ozempic, and Medicare Patients

Breaking news — November 6, 2025, 10 a.m. ET: Former President Donald Trump and CMS Administrator Dr. Mehmet Oz announced a new Trump drug pricing deal with Eli Lilly and Novo Nordisk to cut the cost of popular weight-loss drugs, including Wegovy and Ozempic. The plan introduces Medicare copays as low as $50 a month and a new TrumpRx platform for direct patient access. Here’s what this means for health advocates, patients, and the future of medication affordability.
Doctor measuring an older patient’s waist during a consultation about the Trump drug pricing deal and new Medicare coverage for weight-loss medications.

Breaking News: What the Trump Drug Pricing Deal Means for Patients

The Trump drug pricing deal announced today introduces sweeping changes aimed at lowering the cost of popular weight-loss drugs such as Wegovy and Ozempic. Backed by Eli Lilly & Co. and Novo Nordisk, the plan sets new Medicare copays as low as $50 a month and promises reduced cash-pay prices over the next two years.

CMS Administrator Dr. Mehmet Oz described the initiative as an effort to make advanced weight-management medications more affordable for older Americans. While this announcement signals hope, patients and advocates should understand how these reforms will actually unfold—and what questions to ask next.

The Trump drug pricing deal aims to lower the cost of Wegovy, Ozempic, and other weight-loss drugs for Medicare patients. Learn how to navigate the new policy, assess your eligibility, and use key questions to make the most of upcoming changes through the TrumpRx.gov program.

Video Source: ABC News — “President Trump announces deal to lower weight loss drug prices,” November 6, 2025, via YouTube

Understanding the Trump Drug Pricing Deal

This Trump drug pricing deal affects how the Centers for Medicare & Medicaid Services negotiates with drug manufacturers. The agreements apply first to select GLP-1 weight-loss and diabetes medications, gradually expanding to other high-cost treatments.

For consumers, the details matter:

  • Medicare beneficiaries will see capped monthly copays for approved drugs.
  • Uninsured or privately insured patients may access discounted prices through the upcoming TrumpRx.gov portal, launching in 2026.
  • Pharmacies and health plans will need to update formularies and pricing systems before changes take effect.

To stay informed as the rollout continues, see Drug Price Updates: What’s New and How to Stay Informed for an overview of upcoming Medicare 2026 drug pricing updates.

The Trump drug pricing deal represents an early test of “most-favored-nation” pricing, linking U.S. costs to the lowest prices paid internationally.

Why It Matters for Everyday Consumers

Weight-loss medications have become a cornerstone in managing obesity-related conditions, yet their high price has placed them out of reach for many. The Trump drug pricing deal attempts to close that gap by aligning policy with patient affordability.

However, the rollout will take time. Health advocates should help patients interpret what “price reductions” really mean: initial discounts might apply only to specific doses or patient groups. Transparent communication between patients, providers, and insurers will be essential for avoiding confusion.

Subscribe to our Patient & Caregiver University Newsletter for expert tips and tools to empower your healthcare journey.

* indicates required

Five Questions Patients and Advocates Should Ask to Navigate the New Trump Drug Pricing Deal

Before assuming this new policy will automatically lower costs, it’s important for consumers to pause and analyze what the Trump drug pricing deal could mean for their unique healthcare situation. Because the policy affects drugs, insurance contracts, and coverage timelines differently, understanding its impact requires asking the right people the right questions.

In healthcare, answers don’t always come from one source. Some information must come from your health plan, some from your provider, and some from yourself as you evaluate what fits your medical and financial priorities. These are not casual questions—they are signposts that help you navigate complex policies, refine your analytical thinking, and make well-informed decisions about your treatment options.

Here are five signpost questions that can help you determine how this new plan might affect you and how to make the most of it:

1. How will this policy apply to my specific situation?

Ask: Start with your health-plan representative or Medicare office.
Why: Every insurance plan has its own contract with drug manufacturers. Knowing whether your plan participates in this pricing deal determines if you’ll see immediate savings or need to wait for updates. Asking early allows you to prepare for possible changes in out-of-pocket costs.

2. Does my current medication qualify under the Trump drug pricing deal?

Ask: Your prescribing provider or pharmacist.
Why: The deal focuses on select weight-loss drugs and formulations. Your healthcare team can confirm whether your current prescription or a generic alternative falls under the new pricing model—and whether a dosage adjustment could lower your monthly cost.

3. What actions do I need to take to benefit from these discounts?

Ask: Both your provider and your insurer.
Why: Some programs will automatically apply; others may require you to re-enroll, update your plan, or switch pharmacies. Knowing these steps ensures you don’t miss potential savings once the policy becomes active.

4. How can I track my medication costs as this policy rolls out?

Ask: Yourself—with guidance from a pharmacist or patient advocate.
Why: Keeping a simple record of medication prices, copays, and coverage changes helps you recognize patterns and confirm when cost reductions take effect. These notes can also support appeals or reimbursement requests if errors occur.

5. Who can help me coordinate information between my provider, pharmacy, and insurer?

Ask: Your care coordinator, clinic navigator, or patient advocate.
Why: As coverage changes unfold, communication gaps can delay treatment or lead to unexpected charges. Having a go-to person for coordination strengthens your understanding of your benefits and keeps your treatment uninterrupted.

Each of these questions encourages patients and advocates to think critically—not just about cost, but about timing, eligibility, and coordination. By asking strategically, consumers transform policy news into actionable insight, learning to recognize how government reforms directly influence personal health decisions.

The Coordination and Navigation Perspective

As policies evolve, care coordination and navigation skills will be essential in helping patients adapt. This means ensuring that every step—from verifying eligibility with Medicare to confirming copay adjustments with pharmacies—is communicated clearly among all parties involved.

Patients can practice navigation skills by documenting who they speak with, noting policy changes, and keeping updated copies of any new coverage letters or benefit explanations. Advocates and caregivers can play a central role by helping patients track these interactions and identify any gaps in coverage or service access.

At the same time, patient education is crucial. Patients should understand how to interpret policy updates, compare out-of-pocket estimates, and ask “signpost questions” to clarify coverage changes. By integrating these three competencies—care coordination, patient education, and navigation skills—individuals gain confidence to manage the complexities of evolving drug-pricing systems.

Summary: The Road Ahead and the Launch of TrumpRx.gov

The Trump drug pricing deal is the first of its kind to directly connect national drug-price negotiations with consumer-facing tools. The upcoming TrumpRx.gov website—expected in 2026—will allow patients to compare participating manufacturers’ prices and explore discounts for both insured and uninsured users.

While implementation is still in progress, this policy marks a pivotal shift toward greater transparency in U.S. prescription costs. Patients and advocates alike should stay informed, verify eligibility, and use trusted sources such as CMS.gov and TrumpRx.gov for the latest details.

Do you want to discuss your score?

Disclaimer: This education was brought to you today by The Patient Better Project Inc., a 501(c)(3) organization dedicated to reshaping the way patients and caregivers navigate care. We are committed to empowering individuals with the knowledge and tools necessary to take control of their health journeys, ensuring that everyone can access the care they need with confidence and clarity.

The information provided here is for educational and entertainment purposes only. It is not intended as, nor should it be considered a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. If you think you may have a medical emergency, immediately call 911 or your local emergency number.

Leave a Comment